Please join ORA for monthly virtual Office Hours on the second Thursday of each month at 11:00 am. The schedule of topics is included below with registration links for individual sessions.
If you would like to submit questions for the Q&A ahead of time, please send them to [email protected] or [email protected] with “Office Hours Q&A” in the email subject.
We look forward to hearing from you!
This session will cover navigating the various sections of the ORA website to find information related to proposals, awards, agreements, outgoing subawards, compliance information, and training resources.
Register for the August 8th session here: https://jhjhm.zoom.us/webinar/register/WN__kQufD4SRMymZhFq4TgmrA
Session topic is TBD – please check back closer to the session date.
Register for the September 12th session here: https://jhjhm.zoom.us/webinar/register/WN_mgzoxGrTRNqCzSW_8bNtjg
Session topic is TBD – please check back closer to the session date.
Register for the October 10th session here: https://jhjhm.zoom.us/webinar/register/WN_4lIKitNTQReN89R0x-Zf6A
Session topic is TBD – please check back closer to the session date.
Register for the November 14th session here: https://jhjhm.zoom.us/webinar/register/WN_d1t-npRIQ7u80Qq_fgO-4w
Session topic is TBD – please check back closer to the session date.
Register for the December 12th session here: https://jhjhm.zoom.us/webinar/register/WN_0lIpbfFxSluszxBbh2Rb0A
This session focused on demystifying who we are, what we do, and addressed the question, “what happens after I submit my grant/contract/outgoing subaward, etc. to ORA?” We covered the four ORA teams, team responsibilities, ORA processes, and how to find the ORA contacts assigned to your department.
A recording of the session can be viewed here and a copy of the presentation slides can be downloaded here.
For questions about commercially funded clinical research/clinical trials, please consult the Clinical Research Contracting (CRC) session from May 9th.
This session focused on a JHM Institutional Review Board (IRB) overview, presented by Megan Singleton, Associate Dean for Human Research Protection and Director of the Human Research Protection Program (HRPP). More information about the JHM IRB can be found on their website here.
A recording of the session can be viewed here and a copy of the presentation slides can be downloaded here.
Additional links referenced during the Q&A included:
This session focused on a Clinical Research Contracting (CRC) office overview, presented by Mont Brownlee, Executive Director of CRC. CRC is responsible for the review, negotiation, and signature of all commercially sponsored clinical research and all Confidentiality/Non-Disclosure Agreements (CDA/NDA) for the School of Medicine.
A recording of the presentation can be viewed here and a copy of the presentation slides can be downloaded here.
This session briefly covered research security updates, the new NIH resubmission markup policy, and a refresher on Data Use Agreement and Materials Transfer Agreement routing.
A recording of the presentation portion is available to view here and a copy of the slides can also be downloaded here.
In this session we covered the elements of Just-in-Time submissions for grants.
A recording of the presentation is available to view here and a copy of the slides can also be downloaded here.
Additional resources mentioned during the session include sample automated and formal JIT email requests, and a JIT acronyms list.
As there were a number of Other Support-related questions during the Q&A, we have included a list of available JHU Other Support resources below:
In this session we covered agreement types, Fibi routing, and how to submit various proposal, award, and agreement types to our office.
A recording of the presentation is available to view here and a copy of the slides can also be downloaded.
Fibi resources referenced in the session include the ORIS website and ORA Fibi training page (includes the Coeus to Fibi cheat sheet).
A copy of the slides shared during this session can be found here. Questions and responses from the Q&A portion will be added soon.